يعرض 1,541 - 1,560 نتائج من 1,716 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant point decrease ))~', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1541

    Evaluation of Chemical Potentials, Bulk Modulus and Volume Expansion Ratio of Li-Si Alloys with Variety of Li Concentrations Using First-Principles Calculations (Supporting Informa... حسب Hideaki OHTA (22533225)

    منشور في 2025
    "…However, in the case of LiSi, which has three different polymorphs, significant variation in the bulk modulus is observed. …"
  2. 1542

    Table 1_Development of the breastfed infant oral microbiome over the first two years of life in the BLOSOM Cohort.docx حسب Roaa A. Arishi (21089924)

    منشور في 2025
    "…</p>Methods<p>Infant oral samples (n=667) were collected at ten time points from the first week to year two of life from 84 infants. …"
  3. 1543

    AI-guided EMS for chronic musculoskeletal pain: subgroup-level outcomes from a digital health platform حسب Maja Green (8462307)

    منشور في 2025
    "…</p> <p>Across ~185,000 sessions, users reported significant pain reduction. Mean pain decreased by 2.4 points (<i>p</i> < 0.001), exceeding 30% improvement, with benefits sustained at 12 and 24 months. …"
  4. 1544

    Data Sheet 1_Assessing the impact of climate change on the potential distribution of Keteleeria evelyniana Mast. in southwest China: a Maxent modeling approach.docx حسب Yuan Feng (213823)

    منشور في 2025
    "…Utilizing 221 effective distribution points and 33 environmental variables, the potential distribution of K. evelyniana in current and future climate scenarios was predicted, with the key environmental variables analyzed. …"
  5. 1545

    Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  6. 1546

    Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  7. 1547

    Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  8. 1548

    Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  9. 1549

    Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  10. 1550

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  11. 1551

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  12. 1552

    Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  13. 1553
  14. 1554

    Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  15. 1555

    Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  16. 1556

    Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  17. 1557

    Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

    منشور في 2025
    "…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …"
  18. 1558

    Relationship of different levels of physical activity on the health status of long-term breast cancer survivors: a cross-sectional study حسب Francisco Álvarez-Salvago (21338477)

    منشور في 2025
    "…This inactivity is significantly correlated with greater physical and emotional deterioration.…"
  19. 1559

    Data Sheet 1_Disease burden of tuberculosis in China from 1990 to 2021 and its prediction to 2036.docx حسب Rong Sun (532754)

    منشور في 2025
    "…Period effect and cohort effect showed both incidence and mortality rates significantly decreased with advancing time points and more recent birth cohorts. …"
  20. 1560

    Jaccard Distance to Donor following FMT intervention, as assessed using qiime fmt cc. حسب Chloe Herman (11021226)

    منشور في 2025
    "…The FMT intervention decreases the variability in distance to donor of all recipients. …"